Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Categories
  3. Pharmacology

Pharmacology Research

Browse the latest research summaries in the field of pharmacology for spinal cord injury patients and caregivers.

Showing 171-180 of 639 results

PharmacologyNeurology

Role of CD36 in central nervous system diseases

Neural Regeneration Research, 2024 • March 1, 2024

This review focuses on the role of CD36, a scavenger receptor, in central nervous system (CNS) diseases and explores potential therapeutic strategies involving CD36 antagonists. The review discusses t...

KEY FINDING: CD36 mediates endothelial dysfunction, oxidative stress, mitochondrial dysfunction, and inflammatory responses, contributing to CNS diseases.

Read Summary
PharmacologyPain ManagementResearch Methodology & Design

Muscimol as a treatment for nerve injury-related neuropathic pain: a systematic review and meta-analysis of preclinical studies

Korean J Pain, 2023 • August 1, 2023

This systematic review and meta-analysis evaluated the efficacy of muscimol in ameliorating nerve injury-related neuropathic pain based on preclinical studies. The study found that muscimol is effecti...

KEY FINDING: Muscimol significantly reduces mechanical allodynia (SMD = 1.78 [1.45–2.11]; P < 0.0001; I2 = 72.70%), mechanical hyperalgesia (SMD = 1.62 [1.28–1.96]; P < 0.0001; I2 = 40.66%), and thermal hyperalgesia (SMD = 2.59 [1.79–3.39]; P < 0.0001; I2 = 80.33%).

Read Summary
PharmacologyNutrition & DieteticsDermatology

Simultaneous Administration of Hyperbaric Oxygen Therapy and Antioxidant Supplementation with Filipendula ulmaria Extract in the Treatment of Thermal Skin Injuries Alters Nociceptive Signalling and Wound Healing

Medicina, 2023 • September 17, 2023

This study investigates the effects of hyperbaric oxygen therapy (HBO) and antioxidant supplementation with Filipendula ulmaria extract, individually and simultaneously, in treating thermal skin injur...

KEY FINDING: Simultaneous administration of hyperbaric oxygen therapy and antioxidant supplementation with Filipendula ulmaria extract significantly ameliorated the macroscopic and histopathological characteristics of the wound area and healing.

Read Summary
PharmacologyNeurologyGenetics

Transcriptomic Profiling after In Vitro ∆8-THC Exposure Shows Cytoskeletal Remodeling in Trauma-Injured NSC-34 Cell Line

Pharmaceuticals, 2023 • September 7, 2023

The study explores the effects of ∆8-THC on neuronal cell death and recovery in a trauma-injured NSC-34 motoneuron cell line model. Traumatic scratch injury was induced, and cells were pretreated with...

KEY FINDING: ∆8-THC triggers cytoskeletal remodeling, potentially through activation of the Janus Kinase Signal Transducer and Activator of Transcription (JAK/STAT) signaling pathway and the Mitogen-Activated Protein (MAP) Kinase signaling pathway.

Read Summary
Alternative MedicinePharmacology

Salvianolic Acid B: A Review of Pharmacological Effects, Safety, Combination Therapy, New Dosage Forms, and Novel Drug Delivery Routes

Pharmaceutics, 2023 • August 29, 2023

Salvianolic acid B, extracted from Danshen, exhibits diverse pharmacological effects, including antitumor, anti-inflammatory, antioxidant, and neuroprotective activities, making it a valuable compound...

KEY FINDING: Salvianolic acid B demonstrates antitumor effects by inducing apoptosis, autophagy, and oxidative stress, enhancing T cell activity, and inhibiting EMT and tumor cell proliferation across various cancers.

Read Summary
PharmacologyNeurology

Neuroprotective effects of crude extracts, compounds, and isolated molecules obtained from plants in the central nervous system injuries: a systematic review

Frontiers in Neuroscience, 2023 • September 12, 2023

This systematic review investigated the neuroprotective effects of crude extracts, compound, and isolated molecules obtained from plants in different CNS lesions. Fourteen out of 5,521 studies were se...

KEY FINDING: Crude extracts, compounds, and isolated molecules obtained from plants showed neuroprotective effects against CNS injuries.

Read Summary
Alternative MedicinePharmacologyNeurology

Effects of albiflorin on oxidative stress and inflammatory responses in rats with acute spinal cord injury

Immun Inflamm Dis, 2023 • September 5, 2023

This study revealed that the bioactive compound AF extracted from a peony (R. Paeoniae Alba) could efficiently improve motor function and reduce the loss of neuron cells in SCI rats. AF could reduce i...

KEY FINDING: Albiflorin (AF) administration alleviated motor dysfunction caused by acute SCI in a dose-dependent manner, improving the balancing ability of rats after acute SCI induction.

Read Summary
PharmacologyNeurology

Post-marketing safety surveillance of dalfampridine for multiple sclerosis using FDA adverse event reporting system

Frontiers in Pharmacology, 2023 • September 14, 2023

This study analyzed adverse event (AE) reports of dalfampridine from the FDA Adverse Event Reporting System (FAERS) to investigate its post-marketing safety. The analysis identified 335 AE signals, wi...

KEY FINDING: The study identified 335 AE signals related to dalfampridine, with a higher occurrence in females and individuals aged 45–65, aligning with MS epidemiology.

Read Summary
PharmacologyPain Management

Iatrogenic Side Effects of Pain Therapies

Cureus, 2023 • September 2, 2023

Interventional procedures and drug therapy to reduce pain may introduce iatrogenic side effects. These adverse events range from those that are merely bothersome to those that reduce the quality of li...

KEY FINDING: Interventional pain procedures can lead to nerve or vascular injuries, spinal cord trauma, and epidural abscesses, though these are rare.

Read Summary
PharmacologyNeurologyPain Management

Alleviation of neuropathic pain with neuropeptide Y requires spinal Npy1r interneurons that coexpress Grp

JCI Insight, 2023 • October 12, 2023

This study demonstrates that spinal Npy1r-expressing DH interneurons that coexpress Grp are evolutionarily conserved across rodent, nonhuman primate, and human and are necessary for the efficacy of sp...

KEY FINDING: Y1-INs in the spinal dorsal horn are excitatory neurons that segregate into three distinct subpopulations based on coexpression of Npy1r with Grp, Npff, or Cck.

Read Summary
Previous
1...171819...64
Next